Dynamic Technology Lab Private Ltd Acquires Shares of 18,642 Maximus, Inc. $MMS

Posted by Geri Gentry on Jun 13th, 2026

Dynamic Technology Lab Private Ltd acquired a new stake in Maximus, Inc. (NYSE:MMS – Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 18,642 shares of the health services provider’s stock, valued at approximately $1,609,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in MMS. Norges Bank acquired a new position in Maximus in the 4th quarter valued at $60,393,000. Goldman Sachs Group Inc. grew its holdings in Maximus by 218.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 583,627 shares of the health services provider’s stock valued at $50,379,000 after buying an additional 400,315 shares in the last quarter. Boston Partners grew its holdings in Maximus by 47.0% in the 3rd quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock valued at $88,236,000 after buying an additional 308,892 shares in the last quarter. UBS Group AG grew its holdings in Maximus by 76.8% in the 4th quarter. UBS Group AG now owns 610,354 shares of the health services provider’s stock valued at $52,686,000 after buying an additional 265,095 shares in the last quarter. Finally, Qube Research & Technologies Ltd grew its holdings in Maximus by 115.8% in the 2nd quarter. Qube Research & Technologies Ltd now owns 379,342 shares of the health services provider’s stock valued at $26,630,000 after buying an additional 203,521 shares in the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Stock Performance

NYSE:MMS opened at $62.36 on Friday. The stock’s 50-day simple moving average is $63.46 and its 200 day simple moving average is $75.94. The firm has a market capitalization of $3.28 billion, a PE ratio of 9.34 and a beta of 0.58. The company has a quick ratio of 2.21, a current ratio of 2.21 and a debt-to-equity ratio of 0.87. Maximus, Inc. has a twelve month low of $56.92 and a twelve month high of $100.00.

Maximus (NYSE:MMS – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.98 by $0.09. The business had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.Maximus’s revenue was down 4.1% compared to the same quarter last year. During the same period last year, the firm posted $2.01 earnings per share. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, analysts anticipate that Maximus, Inc. will post 8.43 EPS for the current fiscal year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were given a $0.33 dividend. The ex-dividend date was Friday, May 15th. This represents a $1.32 annualized dividend and a yield of 2.1%. Maximus’s dividend payout ratio (DPR) is currently 19.76%.

Analyst Upgrades and Downgrades

MMS has been the topic of a number of research reports. Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Wall Street Zen raised Maximus from a “hold” rating to a “buy” rating in a report on Saturday, June 6th. Finally, Weiss Ratings cut Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, Maximus currently has an average rating of “Hold”.

Read Our Latest Analysis on Maximus

Insider Buying and Selling

In other Maximus news, Director Jan Madsen sold 742 shares of the stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the completion of the transaction, the director directly owned 20,795 shares in the company, valued at approximately $1,502,438.75. This trade represents a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.80% of the company’s stock.

Maximus Company Profile

(Free Report)

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.